Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Waltham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Xilio Therapeutics, Inc. has filed 351 SEC EDGAR filings since 21 Jan 2021

SEC filing history

Showing 176-200 of 351 matching filings.

Per page
25
Current page
8
4

FORM 4 SUBMISSION

Filing date
16 Jan 2024
Reporting date
11 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Jan 2024
Reporting date
01 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Jan 2024
Reporting date
01 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Jan 2024
Reporting date
01 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Jan 2024
Reporting date
01 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
07 Sep 2023
Reporting date
05 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
07 Sep 2023
Reporting date
05 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Aug 2023
Reporting date
16 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Aug 2023
Reporting date
16 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Aug 2023
Reporting date
16 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Aug 2023
Reporting date
16 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
07 Aug 2023
Reporting date
03 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
07 Aug 2023
Reporting date
03 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .